11-19-2020, 08:14 PM
Covid vaccine front-runners: How much they cost, who’s bought them and how they’re stored
- Two Covid-19 vaccines have been found to be highly effective in late-stage trials in recent days, boosting optimism at a time when health systems in Europe and the U.S. are once again being pushed to breaking point.
- Huge challenges remain before a vaccine can be rolled out, however.
- The global battle to secure prospective supplies has raised alarm about equitable access, while questions remain over logistics, distribution, and, perhaps most significantly, cost.